Core Laboratories Inc.
CLB
$16.28
$0.171.06%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.23% | 17.76% | -104.78% | 236.65% | 26.88% |
| Total Depreciation and Amortization | -2.23% | -2.65% | -3.28% | -5.42% | -6.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -397.31% | 58.47% | -40.86% | -102.81% | -830.21% |
| Change in Net Operating Assets | -241.72% | -84.24% | 81.37% | 17.62% | 89.24% |
| Cash from Operations | -35.08% | -18.80% | 20.43% | 6.10% | 6,277.83% |
| Capital Expenditure | -11.03% | -51.01% | -17.27% | -60.12% | 21.15% |
| Sale of Property, Plant, and Equipment | 14.29% | 364.42% | 107.42% | 1,133.85% | 98.51% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 150.40% | 18.47% | 289.15% | -91.11% | 34,983.33% |
| Cash from Investing | 587.37% | -139.30% | 146.59% | -45.50% | 85.51% |
| Total Debt Issued | -31.25% | 50.00% | -7.14% | -50.00% | -79.75% |
| Total Debt Repaid | 16.67% | 42.86% | 11.76% | 25.93% | 71.08% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2,455.61% | -1,590.74% | -4,495.45% | -174.89% | 10.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.85% | 0.21% | -0.21% | -0.43% | -0.43% |
| Other Financing Activities | -1,122.22% | 122.22% | 101.58% | 100.00% | 87.57% |
| Cash from Financing | -86.41% | 76.62% | -9.85% | -4.84% | -47.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -247.10% | 226.42% | 1,525.12% | -54.88% | 139.41% |